Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04UXX
|
|||
Former ID |
DCL000918
|
|||
Drug Name |
PD-158771
|
|||
Synonyms |
PD 158771; N-[4-[2-(4-phenylpiperazin-1-yl)ethyl]cyclohexyl]pyrimidin-2-amine; Trans-N-(4-(2-(4-Phenyl-1-piperazinyl)ethyl)cyclohexyl)-2-pyrimidinamine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Schizophrenia [ICD-11: 6A20] | Preclinical | [1] | |
Company |
Pfizer
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H31N5
|
|||
Canonical SMILES |
C1CC(CCC1CCN2CCN(CC2)C3=CC=CC=C3)NC4=NC=CC=N4
|
|||
InChI |
1S/C22H31N5/c1-2-5-21(6-3-1)27-17-15-26(16-18-27)14-11-19-7-9-20(10-8-19)25-22-23-12-4-13-24-22/h1-6,12-13,19-20H,7-11,14-18H2,(H,23,24,25)
|
|||
InChIKey |
OUUMPVSFLSOGJZ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 189152-50-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.